CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 7th, 2017 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Change in Control and Severance Agreement (this “Agreement”) is entered into by and between [·] (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on March 6, 2017 (the “Effective Date”).
March 6, 2017Loxo Oncology, Inc. • March 7th, 2017 • Pharmaceutical preparations • New York
On behalf of Loxo Oncology, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) is very pleased to offer you this amended and restated employment agreement (the “Agreement”):
